Skip to Content

News Releases

News Releases

Date Title and Summary
Toggle Summary BioScrip to Participate in Upcoming Investor Conferences
DENVER , May 16, 2018 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that Daniel E. Greenleaf , President and Chief Executive Officer, and Stephen M.
Toggle Summary BioScrip Reports First Quarter 2018 Financial Results
DENVER , May 10, 2018 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced its first quarter 2018 financial results. First Quarter 2018 Highlights Net revenue of
Toggle Summary BioScrip Schedules Release of First Quarter 2018 Financial Results and Conference Call
DENVER , April 26, 2018 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that the Company will issue its financial results press release for the first quarter
Toggle Summary BioScrip Timely Files Annual Form 10-K, Concludes Accounting Review and Provides Update on Immaterial Financial Statement Corrections
DENVER , March 26, 2018 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that the Company has filed timely its Annual Report on Form 10-K for the year ended
Toggle Summary BioScrip Provides Update on Annual Form 10-K Filing Status
DENVER --(BUSINESS WIRE)--Mar. 15, 2018-- BioScrip, Inc. (NASDAQ: BIOS) (" BioScrip " or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that it will be filing a Form 12b-25 with the U.S.
Toggle Summary BioScrip Reports Fourth Quarter and Full Year 2017 Financial Results
DENVER --(BUSINESS WIRE)--Mar. 8, 2018-- BioScrip, Inc. (NASDAQ: BIOS) (" BioScrip " or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced its preliminary 2017 financial results and provided financial guidance for 2018, subject
Toggle Summary BioScrip Schedules Release of Fourth Quarter and Full Year 2017 Financial Results and Conference Call
DENVER --(BUSINESS WIRE)--Feb. 22, 2018-- BioScrip, Inc. (NASDAQ: BIOS) (" BioScrip " or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that the Company will issue its financial results press release for the fourth quarter
Toggle Summary BioScrip Announces U.S. Congress Passage of Medicare Home Infusion Transition Benefit, Effective 2019
DENVER --(BUSINESS WIRE)--Feb. 9, 2018-- BioScrip, Inc. (NASDAQ:BIOS) (" BioScrip " or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that the U.S. Congress today passed the Medicare Home Infusion Therapy Access Act of 2017
Toggle Summary BioScrip Announces Availability of HEMLIBRA® for Hemophilia Patients
DENVER , Jan. 08, 2018 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that it can now dispense and administer HEMLIBRA® (emicizumab-kxwh), a U.S.
Toggle Summary BioScrip to Host Meetings at the Mizuho Investor Conference
DENVER , Nov. 30, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that Daniel E. Greenleaf , President and Chief Executive Officer, and Stephen Deitsch ,